GP5 and viral infectious disease: In 2019, a DNA vaccine candidate containing PRRSV GP5-Mosaic sequences was shown to be immunogenic and induced protection of pigs against virus infection, supporting the potential for the mosaic vaccine to provide broader protection against emerging PRRSV variants [121,122].